This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Dipharma Francis S.r.l.
Dipharma Francis S.r.l., headquartered in Italy, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Founded in 1946, the company has established a strong presence in Europe and beyond, focusing on high-quality products tailored for the global market. With a commitment to innovation, Dipharma offers a diverse range of services, including custom synthesis and contract manufacturing, which set it apart from competitors. The company is recognised for its expertise in complex chemical processes and its dedication to sustainability. Over the years, Dipharma has achieved significant milestones, solidifying its market position as a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does Dipharma Francis S.r.l.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dipharma Francis S.r.l.'s score of 14 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dipharma Francis S.r.l.'s reported carbon emissions
Dipharma Francis S.r.l., headquartered in Italy, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary and does not inherit emissions data from a parent organization. Despite the lack of specific emissions data, Dipharma Francis S.r.l. is committed to addressing climate change through various initiatives. However, there are no documented reduction targets or climate pledges available at this time. The absence of specific targets may suggest that the company is in the early stages of developing a comprehensive climate strategy. As a part of the pharmaceutical industry, which is increasingly focusing on sustainability, Dipharma Francis S.r.l. may align its future commitments with industry standards and best practices. This could include potential participation in initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) to enhance transparency and accountability in their climate actions. Overall, while specific emissions data and reduction targets are not currently available, Dipharma Francis S.r.l. is positioned within a sector that is progressively prioritising climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dipharma Francis S.r.l. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
